Investigation into cardiac sympathetic innervation during the commencement of haemodialysis in patients with chronic kidney disease
Tóm tắt
Patients with chronic kidney disease (CKD) who undergo chronic haemodialysis (HD) show altered sympathetic tone, which is related to a higher cardiovascular mortality. The purpose of this study was to investigate the effect of transition from pre-HD to HD on cardiac sympathetic innervation. Eighteen patients aged 58 ± 18 years (mean ± standard deviation [SD]), 13 males and five females, with stage 5 CKD and nine healthy control subjects aged 52 ± 17 (mean ± SD), three males and six females, were included in this prospective study between May 2010 and December 2013. All patients underwent 123I-labelled meta-iodobenzylguanidine (123I-MIBG) scintigraphy for cardiac sympathetic innervation and electrocardiographically gated adenosine stress and rest 99mTc-labelled tetrofosmin single-photon emission computed tomography for myocardial perfusion imaging prior to (pre-HD) and 6 months after the start of HD. Results of 123I-MIBG scans in patients were compared to controls. Impaired cardiac sympathetic innervation was defined as late heart-to-mediastinum ratio (HMR) < 2.0. Mean late HMR was lower in patients during HD (2.3) than in controls (2.9) (p = 0.035); however, in patients it did not differ between pre-HD and after the start of HD. During HD, two patients showed new sympathetic innervation abnormalities, and in three patients innervation abnormalities seemed to coincide with myocardial perfusion abnormalities. CKD patients show cardiac sympathetic innervation abnormalities, which do not seem to progress during the maintenance HD. The relationship between sympathetic innervation abnormalities and myocardial perfusion abnormalities in HD patients needs further exploration.
Tài liệu tham khảo
Ewing DJ, Winney R (1975) Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 15:424–429
Ritz E, Deppisch R, Stier E, Hänsch G (1994) Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 9:165–172
Tonelli M, Wiebe N, Culleton B et al (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047
McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26
Dasselaar JJ, Slart RH, Knip M et al (2009) Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 24:604–610
Biagini E, Schinkel AF, Bax JJ et al (2005) Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart 91:737–742
Laukkanen JA, Kurl S, Lakka TA et al (2001) Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 38:72–79
Nakata T, Miyamoto K, Doi A et al (1998) Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5:579–590
Santoro A, Mandreoli M (2014) Chronic renal disease and risk of cardiovascular morbidity-mortality. Kidney Blood Press Res 39:142–146
Sasano T, Abraham R, Chang KC et al (2008) Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 51:2266–2275
Chrapko BE, Jaroszyński AJ, Głowniak A et al (2011) Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report. Nucl Med Commun 32:515–521
Kidney Disease (2012) Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2:337–414
Flotats A, Carrió I, Agostini D, EANM Cardiovascular Committee; European Council of Nuclear Cardiology et al (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812
Germano G, Kavanagh PB, Waechter P et al (2000) A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 41:712–719
Kurata C, Wakabayashi Y, Shouda S et al (1995) Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 36:2037–2043
Kurata C, Uehara A, Sugi T et al (2000) Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84:312–319
Chrapko BE, Bednarek-Skublewska A, Staśkiewicz G, Książek A (2012) Relationship of haemodialysis therapy duration and cardiac adrenergic system function assessed by iodine-123 metaiodobenzylguanidine imaging in haemodialysed nondiabetic patients. Nucl Med Commun 33:155–163
Hartmann F, Ziegler S, Nekolla S et al (1999) Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 81:262–700
Schwitter J, Wacker CM, Wilke N et al (2013) MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 34:775–781
Annual Data Report, US Renal Data System, USRDS (2012) National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA. DOI: https://doi.org/10.1053/j.ajkd.2012.11.031
Wan C, Herzog CA, Zareba W, Szymkiewicz SJ (2014) Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 19:247–257
Jacobson AF, Senior R, Cerqueira MD et al (2010) ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55:2212–2221